Irisin levels significantly higher in patients with both EAH and EC. »
09/30/25

Disease progression primary reason for treatment discontinuation. »
09/30/25

High miR-423-5p expression correlated with less aggressive tumor phenotype and improved survival. »
09/30/25

Both DUSP8 enforced expression and silencing dramatically affect gliomagenesis. »
09/30/25

Extracellular acidosis – hallmark of OS aggressiveness – amplified IL-6 release. »
09/30/25

Moderate increase in testicular cancer incidence observed. »
10/01/25

Early clearance of cEBV-DNA associated with significantly greater tumor volume reduction. »
10/02/25

Potential of Daunorubicin HCl and Pyrvinium Pamoate as novel first-line therapies. »
10/01/25

Surgical resection following high-dose PBT can be safely performed. »
10/01/25

Impairing p23 succinylation disrupts its interaction with HSC70. »
10/02/25